Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecloderm vs Lotricomb vs Vehicle in Inflamed Cutaneous Candidiasis
2022-501415-14-00Phase 3Authorised
- Sponsor
- Dermapharm
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cutaneous candidiasis comparing Mecloderm Ointment, Lotricomb Ointment and Vehicle to Mecloderm Ointment (3 arms). Primary endpoint: Treatment success at EOT (visit 3, day 14). Planned start May 2024; status: authorised.
02
Drugs
meclocyclineclotrimazole + betamethasone dipropionate
03
Conditions
cutaneous candidiasis
Beyond the preview
Go deeper on 2022-501415-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501415-14-00.